July 2024
Closing Fasciotomies
A new look at the various options available A review article recently published in JAAOS by Shafic S. et al reviewed the challenges and options available to surgeons when attempting to close a fasciotomy.
April 2017
DermaClose joins Synovis MCA
WCT and DermaClose Join Synovis Micro Companies Alliance Today Wound Care Technologies, Inc. (WCT)—maker of the DermaClose® Continuous External Tissue Expander—announced it will join Synovis Micro Companies Alliance (MCA), a wholly owned subsidiary
February 2017
We now have ISO 13485 certification
FOR IMMEDIATE RELEASE Wound Care Technologies, Inc. Achieves ISO 13485 Certification. An important quality control criterion for international markets. Chanhassen, MN, February 16, 2017 – Wound Care Technologies, Inc. is pleased to have received
April 2016
Don’t miss us at the Orthopedic Trauma Course in San Francisco
Come see us April 28th through 30th at the 11th Annual International San Francisco Orthopedic Trauma Course. We will be on 4th floor at the InterContinental San Francisco hotel on Howard Street. There will be approximately 475-525 attendees. The
DermaClose Now Available at UAB Hospital
Wound Care Technologies, Inc. is pleased to announce that the DermaClose Continuous External Tissue Expander is now available at The University of Alabama Birmingham Hospital (UAB) and its centers. After a thorough review of the clinical
February 2016
Press Release: February 23, 2016
PRESS RELEASE Contact: Paul Anderson WCT, Inc. CEO 952-937-2804 panderson@dermaclose.com FOR IMMEDIATE RELEASE WCT, INC. ANNOUNCES DERMACLOSE HAS BEEN USED IN OVER 15,000 CASES Eden Prairie, MN February 23, 2016 – Wound Care Technologies, Inc.
January 2016
New Reimbursement Information
DermaClose is proud to announce the new commonly billed CPT codes for reimbursement, as well as a guide that showing the cost saving incurred with DermaClose vs NPWT, vessel loops, and skin grafting. Bottom line,
A new milestone
We are pleased to announce that DermaClose has reached a new milestone. DermaClose has now been used in over 15,000 cases to date! There are also now 42 case reports and more coming in almost
DermaClose helps reduce the risk of total ankle arthroplasty (TAA) complications
Duke University Medical Center has recently begun using DermaClose in their total ankle arthroplasty surgeries. Despite surgical improvements, the incidence of complications arising from TAA wound healing remains unacceptably high (up to 28%). These complications
Come see us at AAOS Booth #1302, March 2-4 in Orlando
We will also be exhibiting at AAOS at the Orange County Convention Center in Orlando. Come see us at booth #1302 and see how DermaClose is helping orthopedic surgeons just like you avoid skin grafts
